I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| B cell | 10 studies | 21% ± 6% | |
| CD8-positive, alpha-beta T cell | 7 studies | 25% ± 8% | |
| CD4-positive, alpha-beta T cell | 6 studies | 32% ± 10% | |
| natural killer cell | 6 studies | 21% ± 5% | |
| regulatory T cell | 5 studies | 19% ± 2% | |
| non-classical monocyte | 4 studies | 24% ± 7% | |
| epithelial cell | 4 studies | 34% ± 10% | |
| plasmablast | 3 studies | 39% ± 11% | |
| conventional dendritic cell | 3 studies | 27% ± 7% | |
| pro-B cell | 3 studies | 23% ± 4% | |
| ciliated cell | 3 studies | 23% ± 3% | |
| germinal center B cell | 3 studies | 20% ± 1% | |
| GABAergic neuron | 3 studies | 24% ± 3% | |
| glutamatergic neuron | 3 studies | 30% ± 6% | |
| plasmacytoid dendritic cell | 3 studies | 22% ± 4% | |
| effector CD8-positive, alpha-beta T cell | 3 studies | 22% ± 3% | |
| CD4-positive, alpha-beta memory T cell | 3 studies | 18% ± 0% |
